Innoviva
INVA
#5097
Rank
NZ$2.71 B
Marketcap
NZ$36.36
Share price
1.25%
Change (1 day)
10.74%
Change (1 year)

Earnings for Innoviva (INVA)

Earnings in 2025 (TTM): NZ$0.26 Billion

According to Innoviva's latest financial reports the company's current earnings are NZ$0.38 Billion. In 2024 the company made an earning of NZ$64.73 Million a decrease over its 2023 earnings that were of NZ$0.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Innoviva from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$0.26 B307.3%
2024 NZ$64.73 M-80.74%
2023 NZ$0.33 B-32.36%
2022 NZ$0.49 B-35.56%
2021 NZ$0.77 B25.7%
2020 NZ$0.61 B52.11%
2019 NZ$0.40 B10.77%
2018 NZ$0.36 B56.59%
2017 NZ$0.23 B125.53%
2016 NZ$0.10 B-417.36%
2015 -NZ$32.49 Million-74.49%
2014 -NZ$0.13 Billion-25.19%
2013 -NZ$0.18 Billion430.06%
2012 -NZ$32.11 Million-83.92%
2011 -NZ$0.2 Billion39.82%
2010 -NZ$0.15 Billion2.84%
2009 -NZ$0.14 Billion-8.62%
2008 -NZ$0.16 Billion-47.92%
2007 -NZ$0.3 Billion-5.92%
2006 -NZ$0.32 Billion19.8%
2005 -NZ$0.26 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$31.44 Million-111.60%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.28 Billion-201.89%๐Ÿ‡บ๐Ÿ‡ธ USA